期刊文献+

雌二醇屈螺酮治疗妇女绝经期后症状的临床分析 被引量:4

下载PDF
导出
摘要 目的探讨雌二醇屈螺酮治疗妇女绝经期后症状的改善情况。方法选择100例绝经后妇女,随机分成两组(观察组和安慰空白组),每组均为50例,两组患者均在每日相同时间服用药物,用量为1片,连续观察研究3个月,随访患者记录烘热的频率、严重程度、阴道是否出血情况,观察治疗前后患者烘热频率及严重程度;观察其他症状,如睡眠情况、心悸胸闷、乏力等及血压、阴道出血、子宫内膜厚度等不良反应发生情况。结果观察组治疗前每周中重度烘热次数为(61±32)次/周,治疗后每周中重度烘热次数为(13±9)次/周,安慰空白组治疗前每周中重度烘热次数为(60±33)次/周,治疗后每周中重度烘热次数为(23±12)次/周,治疗前两组的中重度烘热次数比较差异无显著性(P>0.05),治疗后两组的中重度烘热次数比较差异有显著性(P<0.05);临床疗效观察组明显改善32例(64.00%),基本好转15例(30.00%),没有改善3例(6.00%);安慰空白组明显改善13例(26.00%),基水好转18例(36.00%),没有改善19例(38.00%),两组疗效比较差异有显著性(P<0.05),观察组改善绝经期症状明显优于安慰空白组。两组患者均米出现血压大波动、阴道出血、子宫内膜病变等不良反应,组间比较无明显差异。结论雌二醇屈螺酮能够改善妇女绝经后症状,可在临床应用。
作者 张健欣 李博
出处 《中国医刊》 CAS 2012年第12期68-69,共2页 Chinese Journal of Medicine
  • 相关文献

参考文献2

二级参考文献1

同被引文献49

  • 1张茜,薛茜.浅谈系统评价常见的偏倚[J].循证医学,2006,6(2):105-108. 被引量:37
  • 2White WB, Hanes V, Mallareddy M, et al. Effects of the hormone therapy, drospirenone and 17-beta estradiol, on ear- ly morning blood pressure in postmenopausal women with hy- pertension. J Am Soc Hypertens, 2008,2 (1) : 20-27.
  • 3Preston RA,White WB,Pitt B,et al. Effects of drospirenone/ 17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens, 2005,18(6) 797 804.
  • 4Cayan F, Dilek U, Pata O, et al. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, es tradiol-t-drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med, 2008, 5 (1) : 132- 138.
  • 5Collins JA, Blake JM, Crosignani PG. Breast cancer risk with postmenopausal hormonal treatment. Hum Report Up- date, 2005,11(6) : 545-560.
  • 6Higgins JPT, Green S. Cochrane handbook for systematic re- views of interventions version 5.0.2. Weinheim Wiley-WCiVerlag GmbH Co. ,2009:201-203.
  • 7Caruso S, Serra A, Grillo C, et al. Prospective study evalua- ting olfaetometric and rhinomanometric outcomes in postm- enopausal women on 1 mg 17beta-estradiol and 2 mg dro- spirenone HT. Menopause, 2008, 15(5) :967-972.
  • 8Coksuer H, Ozcura F, Oghan F, et al. Effects of estradiol- drospirenone on ocular and nasal functions in postmenopausal women. Climacteric, 2011,14(4) 482-487.
  • 9Chaikittisilpa S, Angsuwathana S, Chaovisitsaree S, et al. Clinical responses to the combination of estradiol and dro- spirenone in symptomatic postmenopausal Thai women. J Med Assoc Thai, 2011,94(9) : 1019-1025.
  • 10Karakus M, Gelisgen R, Topeuogtu A, et al. The effects of 1713-estradiol plus drospirenone on anthropometric and bio- chemical measures of adiposity in menopausal women. Arch Gynecol Obstet, 2012, 286(5) .. 1233-1239.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部